Esther Cho, Chief Legal Officer at Keros Therapeutics, Inc. (KROS), sold 4,485 shares at $10.29 ($46K) on 2026-08-18, disclosed to the SEC on 2026-08-20.
Open-market sale of $46k KROS by Chief Legal Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.